Genetic variability at the amyloid-β precursor protein locus may contribute to the risk of late-onset Alzheimer's disease

Neuroscience Letters

Volumn 269, Issue 2, 1999, Pages 67-70

  Wavrant De Vrièze, Fabienne ^a,e   Crook, Richard ^a   Holmans, Peter ^b,c   Kehoe, Patrick ^b   Owen, Michael J ^b   Williams, Julie ^b   Roehl, Kim ^c   Laliiri, Debomoy K ^d   Shears, Shantia ^c   Booth, Jeremy ^c   Wu, William ^c   Goate, Alison ^c   Chartier Harlin, Marie Christine ^e   Hardy, John ^a   Pérez Tur, Jordi ^a  

^a MAYO CLINIC   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Apolipoprotein E; Genetics; Presenilin 1; Presenilin 2; Sibpairs

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; PRESENILIN 1; PRESENILIN 2;

ALLELE; ALZHEIMER DISEASE; ARTICLE; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENE SEGREGATION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MARKER GENE; PRIORITY JOURNAL; SEGREGATION ANALYSIS; SIBLING;

AGE OF ONSET; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; FEMALE; HUMANS; MALE; MICROSATELLITE REPEATS; NUCLEAR FAMILY;

EID: 0033538502     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00417-6     Document Type: Article

References (28)

1. Bales K.R., Verina T., Dodel R.C., Du Y., Mtstiel L., Bender M., Hyslop P., Jolinstone E.M., Little S.P., Cummins D.J., Piccardo P., Ghetti B., Paul S.M. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet. 17:1997;263-264.
2. Blacker D., Haines J.L., Rodes L., Terwedow H., Go R.C., Harrell L.E., Perry R.T., Bassett S.S., Chase G., Meyers D., Albert M.S., Tanzi R. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology. 48:1997;139-147.
3. Chartier-Harlin M.C., Parfiff M., Legrain S., Pérez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V., et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum. Mol. Genet. 3:1994;569-574.
4. Corder E.H., Saunders A.M., Stritimatter W.J., Schinechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
5. De Strooper B., Saflig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., Van Leuven F. Deficiency of presenilin-l inhibits the normal cleavage of amyloid precursor protein. Nature. 391:1998;387-390.
6. Fox N.W., Johnstone E.M., Ward K.E., Schrementi J., Little S.P. APP gene promoter constructs are preferentially expressed in the CNS and testis of transgenic mice. Biochem. Biophys. Res. Commun. 240:1997;759-762.
7. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
8. Hattori M., Tsukahara F., Furuhata Y., Tanahashi H., Hirose M., Saito M., Tsukuni S., Sakaki Y. A novel method for making nested deletions and its application for sequencing of a 300 kb region of human APP locus. Nucl. Acids Res. 25:1997;1802-1808.
9. Holmans P., Clayton D. Efficiency of typing unaffected relatives in an affected-sib-pair linkage study with single-locus and multiple tightly linked markers. Am. J. Hum. Genet. 57:1995;1221-1232.
10. Kovacs D.M., Wasco W., Witherby J., Felsenstein K.M., Brunel F., Roeder R.G., Tanzi R.E. The upstream stimulatory factor functionally interacts with the Alzheimer amyloid β-protein precursor gene. Hum. Mol. Genet. 4:1995;1527-1533.
11. Krugylak L., Lander E.S. Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am. J. Hum. Genet. 57:1995;1237-1241.
12. Lahiri D.K. An upstream region of the gene promoter for the beta-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells. Mol. Brain Res. 58:1998;112-122.
13. Lahiri D.K., Robakis N.K. The promoter activity of the gene encoding Alzheimer beta-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences. Mol. Brain Res. 9:1991;253-257.
14. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., et al. Candidate gene for the chromosome 1 familial Alzheimer' disease locus. Science. 269:1995;973-977.
15. Pérez-Tur J., Wavrant-De Vrièze F., Lambert J.C., Chartier-Harlin M.C. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 347:1996;1560-1561.
16. Pollwein P., Masters C.L., Beyreuther K. The expression of the amyloid precursor protein (APP) is regulated by two GC-elements in the promoter. Nucl. Acids Res. 20:1992;63-68.
17. Prasher V.P., Farrer M.J., Kessling A.M., Fisher E.M., West R.J., Barber P.C., Butler A.C. Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann. Neurol. 43:1998;380-383.
18. Quitschke W.W., Goldgaber D. The amyloid beta-protein precursor promoter. A region essential for transcriptional activity contains a nuclear factor binding domain. J. Biol. Chem. 267:1992;17362-17368.
19. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am. J. Hum. Genet. 46:1990;222-228.
20. Rooke K., Goate A., Fidani L., Mullan M., Roques P., Rossor M., Hardy J., ChartierHarlin M.C. Screening of the promoter and the β-amyloid sequence of the APP gene for polymorphism in families with late onset Alzheimer's disease. Neurodegeneration. 1:1993;237-240.
21. Rumble B., Retallack R., Hilbich C., Simms G., Muithaup G., Martins R., Hockey A., Montgomery P., Beyreuther K., Masters C.L. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 320:1989;1446-1452.
22. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Vutanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:1996;864-870.
23. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
24. Song W., Lahiri D.K. Molecular cloning of the gene encoding the Rbesus monkey β-amyloid precursor protein: structural characterization of the promoter and comparative study with other species. Gene. 217:1998;151-164.
25. Song W., Lahri D.K. Functional identification of the promoter of the gene encoding the Rhesus monkey β-amyloid precursor protein. Gene. 217:1998;165-176.
26. Vostrov A.A., Quitschke W.W. The zinc finger protein CTCF binds to the APB beta domain of the amyloid beta-protein precursor promoter. Evidence for a role in transcriptional activation. J. Biol. Chem. 272:1997;33353-33359.
27. Wragg M., Hutton M., Talbot C. Alzheimer's Disease Collaborative Group. Genetic association between intronic polymorphism in presenilin-1gene and late-onset Alzheimer's disease. Lancet. 347:1996;509-512.
28. Zaidi S.H., Malter J.S. Nucleolin and heterogeneous nuclear ribonucleoprotein C proteins specifically interact with the 5′-untranslated region of amyloid protein precursor mRNA. J. Biol. Chem. 270:1995;17292-17298.